期刊文献+

他汀类药物辅助治疗慢性阻塞性肺疾病的潜力

下载PDF
导出
摘要 他汀类药物在抑制炎症和慢性阻塞性肺疾病(COPD)气道重塑方面具有多重作用。该药通过抑制鸟苷三磷酸酶和细胞核因子κB介导的炎症活化及细胞重塑途径而对肺及组织具有抗炎作用,可抑制细胞因子的产生(肿瘤坏死因子α、白细胞介素-6和白细胞介素-8),阻止嗜中性粒细胞对肺的渗入;抑制可导致肺小气道纤维化和不可逆性气流受限的肺纤维化;对骨骼肌具有抗氧化、抗白细胞介素-6介导的炎症作用;降低肺部感染的炎症应答。他汀类药物对COPD具有辅助治疗潜力。
出处 《医药导报》 CAS 2011年第12期1629-1632,共4页 Herald of Medicine
  • 相关文献

参考文献32

  • 1MANNINO D M,WATT G,HOLE D,et al.The natural his-tory of chronic obstructive pulmonary disease[J].Eur Respir J,2006,27(4):627-643.
  • 2RENNARD S I.Inflammation in COPD:a link to systemic co-morbidities[J].Eur Respir Rev,2007,16(1):91-97.
  • 3STOCKLEY R A.Neutrophils and the pathogenesis of C-OPD[J].Chest,2002,121(Suppl 5):151-155.
  • 4IHO S,TANAKA Y,TAKAUJI R,et al.Nicotine induces human neutrophils to produce IL-8 through the generation of peroxynitrite and subsequent activation of NF-B[J].J Leukoc Biol,2003,74(8):942-951.
  • 5GAN W Q,MAN S F P,SENTHILSELVAN A,et al.Asso-ciation between chronic obstructive pulmonary disease and systemic inflammation:a systematic review and a meta-analysis[J].Thorax,2004,59(5):574-580.
  • 6BARNES P J,CELLI B R.Systemic manifestations and co-morbities in COPD[J].Eur Respir J,2009,33(8):1165-1185.
  • 7ROMAN J,RITZENTHALER J D,GIL-ACOSTA A,et al.Nicotine and fibronectin expression in lung fibroblasts:implications for tobacco-related lung tissue remodeling[J].FASEB J,2004,18(9):1436-1438.
  • 8CARLISLE D L,HOPKINS T M,GAITHER-DAVIS A,et al.Nicotine signals through muscle-type and neuronal nicotinic acetylcholine receptors in both human bronchial epithelial cells and airway fibroblasts[J].Respir Res,2004,5(1):1-16.
  • 9ALTOSE M D.Approaches to slowing the progression of COPD[J].Curr Opin Pulm Med,2003,9(1):125-130.
  • 10ABBOUD R T,VIMALANATHAN S.Pathogenesis of CO-PD.Part I.The role of protease-antiprotease imbalance in emphysema[J].Int J Tuberc Lung Dis,2008,12(2):361-367.

二级参考文献12

  • 1王悦虹,白春学,毛翎,张敏.血管内皮生长因子及其受体在肺气肿患者肺组织中的表达[J].中华内科杂志,2005,44(4):276-279. 被引量:11
  • 2中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊疗指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(8):17-18.
  • 3Mannnino DM, Davis KJ. Lung function decline and outcomes in an elderly popuhne. Thorax ,2006,61:472-477.
  • 4Shepherd J,Cobbe SM,Ford I, et al. Prevention of coronary heart disease with pravastation in men with hypercholesterolemia. West of Scotland Coronary Prevention Group. N Engl J Med, 1995,333: 1301-1307.
  • 5Cosio Piqueras MG, Cosio MG. Disease of the airway in chronic obstruction pulmonary disease . Eur Respir J, 2001,18 Suppl :41S- 49S.
  • 6Kanazawa H. Role of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Med Sci Monit ,2007,13 : RA189-195.
  • 7KasaharaY,Tuder RM, Cool CD, et al. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growthfactor receptor 2 in emphysema. Am J Respir Crit Care Med,2001,163:737-744.
  • 8Takahashi S, Nakamurea H, Seki M, et al. Reversal of elastase - induced pulmonary emphysema and promotion of alveolar epithelial cell proliferation by simvastatin in mice. Am J Physiol Lung Cell Mol Physiol,2008,294 : L882-L890.
  • 9Keddissi JI, Younis WG, Chbeir EA, et al. The use of Statins and lung function in current and former smokers. Chest, 2007, 132: 1764-1771.
  • 10Alexeeff SE, Litonjua AA, Sparrow D, et al . Statin use reduces decline in lung function : VA Nomative Aging Study. Am J Respir Crit Care Med ,2007,176:742-747.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部